InsightRX – which provides cloud-based precision medicine software to optimize treatment decisions – today announced three major enhancements to current precision dosing solutions based on recent scientific and technological breakthroughs, as well as expansion into new therapeutic areas.
|
[28-November-2023] |
Precision dosing pioneer to unveil details of new scientific and technological breakthroughs SAN FRANCISCO, Nov. 28, 2023 /PRNewswire/ -- InsightRX – which provides cloud-based precision medicine software to optimize treatment decisions – today announced three major enhancements to current precision dosing solutions based on recent scientific and technological breakthroughs, as well as expansion into new therapeutic areas. InsightRX executives will be at Booth 566 of the American Society of Healthcare Pharmacists (ASHP) Midyear 2023 conference in Anaheim, Calif., from Dec. 3-7, to discuss these product enhancements and the science behind them. A more accurate vancomycin PK dosing model for adult patients An exclusive MIPD feature enabling more accurate predictions To help overcome this challenge and improve the predictive accuracy of models in the presence of measured levels, InsightRX developed a feature called InsightRX FitAssistSM that assesses a patient, PK model, and measured level(s), and determines whether the use of "MAP Bayesian with flattened priors" is likely to improve predictions. The FitAssist algorithm shows up to a 74% improvement in prediction accuracy. FitAssist is a complimentary optional feature for all organizations using InsightRX Nova, and currently is applicable to the Buelga, Goti and Thomson models in the vancomycin (adults) module. A new model for adult vancomycin patients with Class III Obesity Building upon proven results InsightRX continues to advance precision dosing intelligence, extending the benefits of precision medicine – highlighted above for vancomycin – to even more patients by enabling individualization of treatments across a wide range of medications and therapeutic areas. The InsightRX team will also be discussing how its software enables MIPD for more antibiotics, such as beta lactams, as well as more categories of medications, including anticoagulants and antifungals. Come by the InsightRX booth 566 to discuss how precision dosing solutions can help advance clinical practice for your organization. About InsightRX Media Contact
SOURCE InsightRX |